Assessment of Early Treatment Response by Diffusion and Perfusion MRI in Patients With Brain Metastasis



Status:Recruiting
Conditions:Cancer, Brain Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:11/10/2018
Start Date:October 2013
End Date:October 2019
Contact:Kathryn Beal, MD
Phone:212-639-5159

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the
body using magnetic field and radio frequency pulses that can not be felt. The purpose of
this study is to determine if new imaging methods can help tumor evaluation in the brain. The
extra images will be obtained using diffusion and perfusion MRI techniques to assess early
treatment response in patients with brain metastasis, and will be compared to methods
currently being used.


Inclusion Criteria:

- Adults aged 18 and over.

- Patients/Subjects able to give informed consent

- Patients/Subjects whose weight does not exceed 275 lbs.

- Patient with metastatic brain tumors greater than or equal to 1.0 cm that will be
treated with stereotactic radiosurgery and scheduled for an MRI scan as part of their
routine care

Exclusion Criteria:

- Patients who are unwilling or unable to undergo MRI including patients with
contra-indications to MRI such as the presence of cardiac pacemakers or non-compatible
intracranial vascular clips.
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center
1275 York Ave
New York, New York 10021
(212) 639-2000
Principal Investigator: Kathryn Beal, MD
Phone: 212-639-5159
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
?
mi
from
New York, NY
Click here to add this to my saved trials